| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201203 | Ophthalmology | 2015 | 7 Pages |
Abstract
Ocriplasmin treatment in this population seems to be generally safe and well tolerated and resulted in more patients achieving VMA resolution and PVD with less anti-VEGF use compared with sham treatment.
Keywords
SAEper-protocol setVFQ-25PVDSD-OCTBCVAETDRSiOpSRFVMAAMDFASPpsOctbest-corrected visual acuityfull analysis setOptical coherence tomographyspectral domain optical coherence tomographyposterior vitreous detachmentearly treatment diabetic retinopathy studyage-related macular degenerationadverse eventSerious adverse eventconfidence intervalVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)Intraocular pressureSubretinal fluidvitreomacular adhesion
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Roger L. MD, PhD, Giovanni MD, Aniz MD, Nirodhini MD, Michael MD,